Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study

Kidney International

Volumn 58, Issue 4, 2000, Pages 1703-1710

  Festa, Andreas ^a,b,c   D’Agostino, Ralph ^a,b,c   Howard, George ^a,b,c   Mykkänen, Leena ^a,b,c   Tracy, Russell P ^a,b,c   Haffner, Steven M ^a,b,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Albumin to creatinine ratio; C reactive protein; Cardiovascular disease; End stage renal disease; Nephropathy; Urinary albumin excretion

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE;

ADULT; ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; URINARY EXCRETION;

EID: 0033807476     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00331.x     Document Type: Article

References (76)

1. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
2. Predicting diabetic nephropathy in insulin-dependent patients
3. Microalbuminuria predicts mortality in noninsulin-dependent diabetes
4. Prospective study of microalbuminuria as predictor of mortality in NIDDM
5. Eight to nine year mortality in known non-insulin dependent diabetics and controls
6. Albuminuria and poor glycemic control predict mortality in NIDDM
7. Albumin excretion and vascular deaths in NIDDM
8. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality
9. Microalbuminuria as predictor of vascular disease in non-diabetic subjects
10. Microalbuminuria as predictor of increased mortality in elderly people
11. Hyperinsulinemic microalbuminuria: A new risk indicator for coronary heart disease
12. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
13. C-reactive protein: Binding to lipids and lipoproteins
14. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
15. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
16. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
17. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
18. Production of C-reactive protein and risk of coronary events in stable and unstable angina
19. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
20. Plasma concentration of C-reactive protein and risks of developing peripheral vascular disease
21. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
22. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men
23. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
24. CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-C-reactive protein complexes
25. Interleukin-6 exacerbates early atherosclerosis in mice
26. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy
27. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy
28. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy
29. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus
30. Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus
31. Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria
32. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM
33. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study
34. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction
35. Chronic subclinical inflammation as part of the insulin resistance syndrome
36. The Insulin Resistance Atherosclerosis Study (IRAS): Objectives, design and recruitment results
37. Assessment of insulin sensitivity in vivo
38. MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test
39. Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects
40. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: Suitability for use in population studies
41. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance
42. Automated determination of urinary creatinine without sample dilution: Theory and practice
43. Microalbuminuria in diabetes: A population study of the prevalence and an assessment of three screening tests
44. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria
45. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens
46. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference interval and epidemiological applications
47. The measurement of fibrinogen in population-based research: Studies on instrumentation and methodology
48. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
49. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance: The Insulin Resistance Atherosclerosis Study (IRAS)
50. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
51. Microalbuminuria and associated cardiovascular risk factors in the community
52. Aspects of haemostatic function in healthy subjects with microalbuminuria: A potential atherosclerotic risk factor
53. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men: Risk Factor Intervention Study Group
54. Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate
55. PAI- 1 and factor VII activity are higher in IDDM patients with microalbuminuria
56. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients
57. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria
58. Physiological inhibitors of blood coagulation and prothrombin fragment F1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy
59. Protein C activation in NIDDM patients
60. Transcapillary escape rate and albuminuria in type II diabetes: Effects of short-term treatment with low-molecular weight heparin
61. Ethnic differences in correlates of microalbuminuria in NIDDM
62. Inflammation in cardiovascular disease: Cart, horse, or both?
63. Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease
64. Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease
65. Is low-level proteinuria an early predictor in acute pancreatitis?
66. Burn and trauma associated proteinuria: The role of lipid peroxidation, renin and myoglobin
67. Microproteinuria: Response to operation
68. Microalbuminuria is an early response following acute myocardial infarction
69. Tumor necrosis factor alpha in glomerular injury
70. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils
71. Microalbuminuria. Implications for micro- and macrovascular disease
72. Pathogenesis of diabetic vascular disease: Evidence for the role of reduced heparan sulfate proteoglycan
73. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects
74. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects
75. THE HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients